← Database
Immunomodulatory Peptide

Thymosin alpha-1

Third-party suppliers · research use only · not an endorsement. Some links are affiliate links — purchases made through them may earn this site a commission.
Overview

Studied in hepatitis, immune support, and as an adjuvant; approved in several countries, not FDA-approved.

How it works

Thymosin alpha-1 is a small fragment of a larger natural protein that helps tune the immune system. Rather than killing pathogens directly, it acts as a modulator — adjusting how immune cells respond.

It influences the maturation and signaling of T cells and dendritic cells and interacts with pattern-recognition (Toll-like) receptors, nudging the immune response toward a more active, balanced state. This is why it's been studied as an add-on in chronic viral infections like hepatitis and as an adjuvant in some cancer settings.

It's approved in several countries and given by injection, but it isn't FDA-approved, and trial results across its proposed uses have been mixed rather than definitive.

Mechanism · Detailed Analysis
Molecular targetA 28-amino-acid fragment of prothymosin-α that modulates innate and adaptive immunity, influencing Toll-like-receptor signalling (TLR2/TLR9) on dendritic cells.
Signaling & downstream effectsPromotes dendritic-cell and T-cell maturation and shifts cytokine balance toward Th1 responses.
CaveatsApproved in some countries; trial results across viral and oncologic indications are mixed.
Published EvidenceLoading cited studies from PubMed…
Human Data ···

Searching the published record…

Animal ···

Searching the published record…

In Vitro ···

Searching the published record…

Educational aggregation of public literature. Not medical advice and not a recommendation to use any compound. Many compounds here are not approved for human use. Consult a licensed clinician.